# An Study of Efficacy and Safety of Clevudine

> **NCT01192854** · PHASE3 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 288 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Clevudine
- **DRUG:** Adefovir

## Key facts

- **NCT ID:** NCT01192854
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2013-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01192854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01192854, "An Study of Efficacy and Safety of Clevudine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01192854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*